Trastuzumab deruxtecan for HER2+ advanced breast cancer.

MLA

Lee, Jiyun, and Yeon Hee Park. “Trastuzumab Deruxtecan for HER2+ Advanced Breast Cancer.” Future Oncology (London, England), vol. 18, no. 1, Jan. 2022, pp. 7–19. EBSCOhost, https://doi.org/10.2217/fon-2021-0550.

APA

Lee, J., & Park, Y. H. (2022). Trastuzumab deruxtecan for HER2+ advanced breast cancer. Future Oncology (London, England), 18(1), 7–19. https://doi.org/10.2217/fon-2021-0550

Chicago

Lee, Jiyun, and Yeon Hee Park. 2022. “Trastuzumab Deruxtecan for HER2+ Advanced Breast Cancer.” Future Oncology (London, England) 18 (1): 7–19. doi:10.2217/fon-2021-0550.